Articles for tag PFDD

LAM & TSC Patient-Focused Drug Development Meeting with the FDA

Posted on March 24, 2017   |   

The TS Alliance, in partnership with The LAM Foundation, is sponsoring a Patient-Focused Drug Development Meeting (PFDD) with the FDA on June 21, 2017, at the Hyatt Regency on Capitol Hill in Washington, DC, from 8:30 a.m. to 4:30 p.m. The purpose of this meeting is for individuals affected by LAM and TSC and caregivers of dependent adults or children to communicate their perspectives on living with LAM and TSC to the FDA. This meeting is free and open to the public, and it will be webcast live online. We hope you will REGISTER and make plans to attend in person or online.

Read More

Topics: LAMposium DC PFDD        Categories: Events
Sign In to Participate
Or register to become a member